• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Rachelle H.B. Fishman

Rachelle H.B. Fishman

Articles

ARTICLES

Non-contact devices deliver more efficient healthcare

July 9, 2010
By Rachelle H.B. Fishman
TEL AVIV, Israel — What new medical device and biotechnology parameters are bolded as the big biomedical and healthcare buyers, scan the flow of hundreds of business plans and proposals from aspiring biomed inventors, entrepreneurs, companies? (Medical Device Daily)
Read More

Cleveland Clinic attracts Israeli companies with its smart money

July 1, 2010
By Rachelle H.B. Fishman
TEL AVIV, Israel – Israel's annual life science industry conference ILSI-Biomed 2010, held here in mid-June, selected 40 of Israel's 400-something startup companies to show off their novel inventions, attract investors and strategic partners, and share war stories. (Medical Device Daily)
Read More

Conference record crowd sees device firms share spotlight

June 30, 2010
By Rachelle H.B. Fishman
TEL AVIV, Israel – A record 7,000 participants, including 1,000 from more than 40 other countries, gathered for the 9th annual Israel Life Science Industry ILSI-Biomed conference and Kenes exhibition here in mid-June. (Medical Device Daily)
Read More

BioLineRx Bringing In $9M For Prodrug Pipeline Work

Sep. 28, 2005
By Rachelle H.B. Fishman

Israeli Chief Scientist Supports Hybrid R&D Biotech Institutes

Aug. 3, 2005
By Rachelle H.B. Fishman

Protalix Series C: $5.3M For Gaucher's Disease Product

July 27, 2005
By Rachelle H.B. Fishman

Israel Sends Delegates To BIO 2005 Annual Convention

June 29, 2005
By Rachelle H.B. Fishman

Bio-Tech Israel 2005 Meeting Focuses On 'Holistic' Attack

June 8, 2005
By Rachelle H.B. Fishman

Intec Pharma Gets New CEO, Plans 'Accordion Pill' Program

May 18, 2005
By Rachelle H.B. Fishman

Can Tissera Revive Plunging Stock Under New Leadership?

April 20, 2005
By Rachelle H.B. Fishman
View All Articles by Rachelle H.B. Fishman

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 11, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • 3D rendering of a molecular glue mediating the interaction between two proteins

    With surface mimicry, molecular glues shed hairpin need

    BioWorld Science
    Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
  • Incurix describes new c-Myc inhibitors

    BioWorld Science
    Incurix Co. Ltd. has identified Myc proto-oncogene protein (c-Myc) inhibitors reported to be useful for the treatment of cancer.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe